BSE: 524588 | NSE: | ISIN: INE379F01019
Market Cap: [Rs.Cr.] 15.70 | Face Value: [Rs.] 10
Forward-looking statements are based on certain assumptions and expectations of futureevents. The Company cannot guarantee that these assumptions and expectations are accurateor will be realized. The Company's actual results, performance or achievements could thusdiffer materially from those projected in any such forward-looking statements. The Companyassumes no responsibility to publicly amend, modify or revise any forward lookingstatements, on the basis of any subsequent developments, information or events.
INDUSTRY STRUCTURE AND DEVELOPMENT
The hospital software and Telemedicine software is being developed in our country, tomeet specific requirements of local hospitals. Non-availability of specialists in town andvillage has given room for networking of the rural hospitals to specialty hospitals incities.
Growth of hospitals and diagnostic centers all over the country has also responsiblefor the development of software in Hospital Operations, Quality Validation, EmergencyCare, etc.
The main business of the company is consultancy of Hospitals, Hospital equipments,diagnostic centers, Medical Insurance, Personal accident policy and other Insurance etc.The Company further diversified as manufacturers, buyers & sellers, importers,exporters, distributors, agents or otherwise deal as Wholesalers or Retailers or Marketersof Medical Equipments, Apparatus, Drugs, Medical, Surgical, Diagnostic equipments,Disposables, Vaccines etc.
During the year the company has not been able to reach its target of generatingbusiness. Threats to be faced by our company are same as of the threats faced by othersmall companies of this industry.
INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
The Company has adequate internal control system that defines roles andresponsibilities of people across various levels of the organization. These systemsfacilitate effective checks and controls as well as tight monitoring orfa continuousbasis.
DISCUSSION ON FINANCIAL PERFORMANCE WITH RESPECT TO OPERATIONAL PERFORMANCE
The financial statements have been prepared in accordance with the requirements of theCompanies Act, 1956 and applicable accounting standards issued by the Institute ofChartered Accountants of India. The details of the financial performance of the companyare appearing in the Balance Sheet, Profit & Loss Accounts and other financialstatements forming part of this annual report. For financial highlights please referheading 'FINANCIAL RESULTS' in Directors report.
HUMAN RESOURCE DEVELOPMENT
The Company feels confident of keeping its manpower costs to below industry norms, withthe emphasis on becoming customer-centric, the staff are regularly exposed to training& Orientation programmes not a only in their respective fields but also in publicrelations.
By Order of the Board of Directors
For Emed.com Technologies Limited
|Place: Hyderabad||KAMLESH D.KORADIYA||PARJESH M. RUPARELIYA|
|Date : 05.09.2013||DIRECTOR||DIRECTOR|
|30-May-14||Emed.com Technologies reports net loss of Rs 0.02 crore in the March 2014 quarter|
|25-Feb-14||Emed.com Technologies reports net profit of Rs 0.03 crore in the December 2013 quarter|
|25-Feb-14||Emed.com Technologies reports nil net profit/loss in the September 2013 quarter|
|25-Feb-14||Emed.com Technologies reports nil net profit/loss in the June 2013 quarter|
|25-Feb-14||Emed.com Technologies reports net loss of Rs 0.10 crore in the March 2013 quarter|
|24-Feb-14||Emed.com Technologies reports nil net profit/loss in the December 2012 quarter|
|30-Oct-14||Lupin's results margins reflect base business strength: IIFL Institutional Report|
|20-Oct-14||Alembic Pharma up 4% post quarterly results|
|01-Oct-14||Apollo Hospital stock up 2% on collaboration with Sanofi|
|30-Sep-14||Apollo Hospitals and Sanofi announce collaboration|
|29-Sep-14||Strides Arcolab surges 6.5%; approves merger with Shasun|
|24-Sep-14||Dr Reddy's launches new drug in US; stock closes up|
P Ratnakar Reddy , Director
M Venu Madhav , Director
M Srikanth Reddy , Director
Shashank Vijay Pawar , Director
Company Head Office / Quarters:
8-2-87/89 4 Flr Left Hand Side,
Srinivasa Plaza Srinagar Colon,
Phone : Andhra Pradesh- / Andhra Pradesh-
Fax : Andhra Pradesh- / Andhra Pradesh-
E-mail : firstname.lastname@example.org
Aarthi Consultants Pvt Ltd
1-2-285,Domalguda,J B Apartments,Hyderabad - 500 029
Check whether Taxed / Tax free investment avenue is better for you
|Taxed Avenue||Tax-Free Avenue|
|Investment amount (Rs.)|
|Tenure of Investment (years)|
|Interest earned (% p.a)|
|Your tax bracket (%)|